References
- Rubenstein JB, Raciti M. Approaches to corneal astigmatism in cataract surgery. Curr Opin Ophthalmol. 2013;24(1):30–34. doi:10.1097/ICU.0b013e32835ac853.
- Ichibe Y, Ishikawa S. Optic neuritis and vitamin C. Nihon Ganka Gakkai Zasshi. 1996;100:381–87.
- Vitetta L, Sali A, Paspaliaris B, Reavley NJ. Megadose vitamin C in treatment of the common cold: a randomised controlled trial. Med J Aust. 2002;176:298–99. doi:10.5694/mja2.2002.176.issue-5.
- Iqbal Z, Midgley JM, Watson DG, Karditsas SD, Dutton GN, Wilson WS. Effect of oral administration of vitamin C on human aqueous humor ascorbate concentration. Zhongguo Yao Li Xue Bao. 1999;20:879–83.
- Blanchard J, Tozer TN, Rowland M. Pharmacokinetic perspectives on megadoses of ascorbic acid. Am J Clin Nutr. 1997;66:1165–71. doi:10.1093/ajcn/66.5.1165.
- Galey I, Bernard BA. Effect of vitamin C and its derivatives on collagen synthesis and cross-linking by normal human fibroblasts. Int J Cosmet Sci. 1998;20:151–58. doi:10.1046/j.1467-2494.1998.171747.x.
- Grobe GM, Reichl S. Characterization of vitamin C-induced cell sheets formed from primary and immortalized human corneal stromal cells for tissue engineering applications. Cells Tissues Organs. 2013;197:283–97. doi:10.1159/000346172.
- Choi KM, Seo YK, Yoon HH, Song KY, Kwon SY, Lee HS, Park JK. Effect of ascorbic acid on bone marrow‐derived mesenchymal stem cell proliferation and differentiation. J Biosci Bioeng. 2008;105:586–94. doi:10.1263/jbb.105.586.
- Shakiba Y, Mostafaie A. Inhibition of corneal neovascularization with a nutrient mixture containing lysine, proline, ascorbic acid, and green tea extract. Arch Med Res. 2007;38:789–91. doi:10.1016/j.arcmed.2007.04.006.
- BenEzra D, Griffin BW, Maftzir G, Sharif NA, Clark AF. Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. Invest Ophthalmol Vis Sci. 1997;38:1954–62.
- Utoguchi N, Ikeda K, Saeki K, Oka N, Mizuguchi H, Kubo K, Nakagawa S, Mayumi T. Ascorbic acid stimulates barrier function of cultured endothelial cell monolayer. J Cell Physiol. 1995;163:393–99. doi:10.1002/(ISSN)1097-4652.
- Knowles HJ, Raval RR, Harris AL, Ratcliffe PJ. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res. 2003;63:1764–68.
- Taniguchi M, Arai N, Kohno K, Ushio S, Fukuda S. Anti‐oxidative and anti‐aging activities of 2-O-alpha-glucopyranosyl-L-ascorbic acid on human dermal fibroblasts. Eur J Pharmacol. 2012;674:126–31. doi:10.1016/j.ejphar.2011.11.013.
- Kim JE, Jin DH, Lee SD, Shin JS, Lee SK, Jung DJ, Kang JS, Lee WJ. Vitamin C inhibits p53‐induced replicative senescence through suppression of ROS production and p38 MAPK activity. Int J Mol Med. 2008;22:651–55.
- Washko P, Rotrosen D, Levine M. Ascorbic acid transport and accumulation in human neutrophils. J Biol Chem. 1989;264:18996–9002.
- Bergsten P, Amitai G, Kehrl J, Dhariwal KR, Klein HG, Levine M. Millimolar concentrations of ascorbic acid in purified human mononuclear leukocytes. Depletion and reaccumulation. J Biol Chem. 1990;265:2584–87.
- Evans RM, Currie L, Campbell A. The distribution of ascorbic acid between various cellular components of blood, in normal individuals, and its relation to the plasma concentration. Br J Nutr. 1982;47:473–82. doi:10.1079/BJN19820059.
- Cho YW, Yoo WS, Kim SJ, Chung IY, Seo SW, Yoo JM. Efficacy of systemic vitamin C supplementation in reducing corneal opacity resulting from infectious keratitis. Medicine. 2014;93(23):e125. doi:10.1097/MD.0000000000000125.